147 related articles for article (PubMed ID: 29321030)
1. CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension.
Celestino R; Nome T; Pestana A; Hoff AM; Gonçalves AP; Pereira L; Cavadas B; Eloy C; Bjøro T; Sobrinho-Simões M; Skotheim RI; Soares P
BMC Cancer; 2018 Jan; 18(1):68. PubMed ID: 29321030
[TBL] [Abstract][Full Text] [Related]
2. Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas.
Cracolici V; Ritterhouse LL; Segal JP; Puranik R; Wanjari P; Kadri S; Parilla M; Cipriani NA
Am J Surg Pathol; 2020 Jul; 44(7):881-892. PubMed ID: 32282345
[TBL] [Abstract][Full Text] [Related]
3. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
[TBL] [Abstract][Full Text] [Related]
4. Follicular thyroid carcinoma: histology and prognosis.
D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
[TBL] [Abstract][Full Text] [Related]
6. Differences in Mutational Profile between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma Identified Using Next Generation Sequencing.
Borowczyk M; Szczepanek-Parulska E; Dębicki S; Budny B; Verburg FA; Filipowicz D; Więckowska B; Janicka-Jedyńska M; Gil L; Ziemnicka K; Ruchała M
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31248021
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
World J Surg; 2006 May; 30(5):767-74. PubMed ID: 16547620
[TBL] [Abstract][Full Text] [Related]
9. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma.
Hawthorn L; Stein L; Varma R; Wiseman S; Loree T; Tan D
Head Neck; 2004 Dec; 26(12):1069-83. PubMed ID: 15515157
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive follicular thyroid carcinomas: prognostic factors.
Stenson G; Nilsson IL; Mu N; Larsson C; Lundgren CI; Juhlin CC; Höög A; Zedenius J
Endocrine; 2016 Aug; 53(2):505-11. PubMed ID: 26858184
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for follicular thyroid carcinoma: the importance of vascular invasion.
Ito Y; Hirokawa M; Masuoka H; Higashiyama T; Kihara M; Onoda N; Miya A; Miyauchi A
Endocr J; 2022 Sep; 69(9):1149-1156. PubMed ID: 35491160
[TBL] [Abstract][Full Text] [Related]
12. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
[TBL] [Abstract][Full Text] [Related]
13. How to define follicular thyroid carcinoma?
Schmid KW; Farid NR
Virchows Arch; 2006 Apr; 448(4):385-93. PubMed ID: 16506015
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis.
Lin CW; Yang WE; Lee WJ; Hua KT; Hsieh FK; Hsiao M; Chen CC; Chow JM; Chen MK; Yang SF; Chien MH
Carcinogenesis; 2016 Jul; 37(7):712-722. PubMed ID: 27207653
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
16. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile.
Metovic J; Vignale C; Annaratone L; Osella-Abate S; Maletta F; Rapa I; Cabutti F; Patriarca S; Gallo M; Nikiforov YE; Volante M; Papotti M
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32936917
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers for discrimination of benign and malignant follicular thyroid tumors.
Fryknäs M; Wickenberg-Bolin U; Göransson H; Gustafsson MG; Foukakis T; Lee JJ; Landegren U; Höög A; Larsson C; Grimelius L; Wallin G; Pettersson U; Isaksson A
Tumour Biol; 2006; 27(4):211-20. PubMed ID: 16675914
[TBL] [Abstract][Full Text] [Related]
18. Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling.
Wojtaś B; Pfeifer A; Jarząb M; Czarniecka A; Krajewska J; Swierniak M; Stokowy T; Rusinek D; Kowal M; Zebracka-Gala J; Tyszkiewicz T; Oczko-Wojciechowska M; Stobiecka E; Lange D; Paschke R; Jarząb B
Endokrynol Pol; 2013; 64(5):328-34. PubMed ID: 24186587
[TBL] [Abstract][Full Text] [Related]
19. Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma.
Kim HJ; Sung JY; Oh YL; Kim JH; Son YI; Min YK; Kim SW; Chung JH
Head Neck; 2014 Dec; 36(12):1695-700. PubMed ID: 24115217
[TBL] [Abstract][Full Text] [Related]
20. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]